On this page
C19orf12
chromosome 19 open reading frame 12
The C19orf12 gene provides instructions for a protein thought to be involved in maintaining lipid balance within mitochondria, and is associated with neurodegenerative conditions such as MPAN. The C19orf12 gene encodes a protein found within the mitochondrial membrane, where it is believed to contribute to lipid homeostasis.
C19orf12 is located on the long (q) arm of chromosome 19, at band 19q12. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 19 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The C19orf12 gene, or chromosome 19 open reading frame 12, is located on chromosome 19. It provides the genetic blueprint for a protein whose precise function is still under investigation, but it is thought to play a role in maintaining cellular health. This gene is primarily associated with neurodegenerative disorders, particularly those affecting movement and brain function.
What the gene does
The C19orf12 gene produces a protein localised to the membrane of mitochondria, which are vital cellular organelles responsible for energy production. While its exact role is not fully understood, research suggests the C19orf12 protein contributes to lipid homeostasis, the process of maintaining a stable balance of fats within the cell. This function is crucial for proper mitochondrial activity and overall cellular metabolism.
Video: Genetics 101
Chromosome location
The C19orf12 gene is situated on the long (q) arm of chromosome 19 at position 12, designated as 19q12. It contains several exons, which are the protein-coding regions of the gene. The gene codes for a protein consisting of 141 amino acids.
Protein structure
The C19orf12 protein is composed of 141 amino acids. Domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Variants in the C19orf12 gene can lead to altered protein function or expression. These genetic changes can range from single base pair substitutions to larger deletions or insertions within the gene. Such variants are often inherited in an autosomal recessive pattern.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.164_166delGGG | - | Pathogenic/Likely pathogenic | ★★☆☆ | C19ORF12-related disorders |
c.161G>A | p.Gly54Glu | Pathogenic/Likely pathogenic | ★★☆☆ | Hereditary spastic paraplegia 43 |
c.166del | - | Pathogenic/Likely pathogenic | ★★☆☆ | Hereditary spastic paraplegia 43 |
c.171_181del | p.Gly58fs | Pathogenic/Likely pathogenic | ★★☆☆ | Autosomal dominant C19orf12-related disorders |
c.172G>A | p.Gly58Arg | Pathogenic/Likely pathogenic | ★★☆☆ | Hereditary spastic paraplegia 43 |
c.205C>T | p.Gln69Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Neurodegeneration with brain iron accumulation 4 |
c.215C>T | p.Pro72Leu | Pathogenic/Likely pathogenic | ★★☆☆ | C19ORF12-related disorders |
c.245del | p.Pro82fs | Pathogenic/Likely pathogenic | ★★☆☆ | Neurodegeneration with brain iron accumulation 4 |
c.-2C>T | T11M | Pathogenic/Likely pathogenic | ★★☆☆ | C19ORF12-related disorders |
c.371dup | p.Met124fs | Pathogenic/Likely pathogenic | ★★☆☆ | Neurodegeneration with brain iron accumulation 4 |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in the C19orf12 gene are primarily associated with mitochondrial membrane protein-associated neurodegeneration (MPAN). This condition is characterised by progressive neurological symptoms, including movement disorders and cognitive decline, often accompanied by iron accumulation in specific brain regions. The gene has also been implicated in other neurodegenerative disorders.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
The C19orf12 gene is included in several NHS Genomic Medicine Service (GMS) approved panels, indicating its clinical relevance for genetic testing in the UK. These panels cover conditions such as 'Dystonia, chorea or related movement disorder, adult onset' and 'Hereditary spastic paraplegia'. It is also part of panels for 'Likely inborn error of metabolism' and 'Neurodegenerative disorders, adult onset', among others.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is mitochondrial membrane protein-associated neurodegeneration (MPAN)?
MPAN is a progressive neurodegenerative disorder caused by variants in the C19orf12 gene. It is characterised by movement problems, neurological issues that worsen over time, and an unusual accumulation of iron in certain parts of the brain.
How is C19orf12 gene variation inherited?
Variants in the C19orf12 gene are typically inherited in an autosomal recessive manner. This means an individual must inherit two copies of the altered gene, one from each parent, to develop the associated condition.
What is the function of the C19orf12 protein?
The C19orf12 protein is found in the membrane of mitochondria and is thought to play a role in lipid homeostasis, which is the process of maintaining a balanced level of fats within cells. Its precise mechanisms are still being investigated.
References
- Kruer MC, Salih MA, Mooney C. C19orf12 mutation leads to a pallido-pyramidal syndrome. Gene. 2014. PMID: 24361204
- Dogu O, Krebs CE, Kaleagasi H. Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. Clinical genetics. 2013. PMID: 23278385
- Landouré G, Zhu PP, Lourenço CM. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Human mutation. 2013. PMID: 23857908
- Deschauer M, Gaul C, Behrmann C. C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. Journal of neurology. 2012. PMID: 22584950
- Hartig MB, Iuso A, Haack T. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. American journal of human genetics. 2011. PMID: 21981780